E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/10/2015 in the Prospect News PIPE Daily.

Medicure plans to conduct C$3.5 million private placement of its stock

Brokered offering slated to fund product development, working capital

By Devika Patel

Knoxville, Tenn., June 10 – Medicure Inc. said it has arranged a C$3.5 million private placement of stock with a 15% greenshoe.

The company will sell 1,590,909 common shares at C$2.20 each. The price per share is a 6.38% discount to C$2.35, the June 9 closing share price.

Settlement is expected July 8.

The deal will be conducted on a bought-deal basis by a syndicate of underwriters led by PI Financial Corp. and including Bloom Burton & Co.

Proceeds will be used for product development, general corporate and working capital purposes.

Medicure is a biopharmaceutical company based in Winnipeg, Man.

Issuer:Medicure Inc.
Issue:Common stock
Amount:C$3.5 million
Greenshoe:15%
Shares:1,590,909
Price:C$2.20
Warrants:No
Underwriters:PI Financial Corp. (lead), Bloom Burton & Co.
Pricing date:June 10
Settlement date:July 8
Stock symbol:TSX Venture: MPH
Stock price:C$2.35 at close June 9
Market capitalization:C$29.43 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.